| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1018 | 16 | 835 | 80 | 974 | 171 | 1041 |
| ERLYTX | 86 | 1 | 52 | 4 | 49 | 7 | 43 |
| GI | 187 | 0 | 0 | 9 | 110 | 22 | 134 |
| GU | 419 | 2 | 104 | 22 | 268 | 52 | 317 |
| LEUK | 140 | 3 | 157 | 9 | 110 | 21 | 128 |
| LUNG | 174 | 4 | 209 | 13 | 158 | 35 | 213 |
| LYMPH | 397 | 1 | 52 | 19 | 231 | 52 | 317 |
| MELAN | 275 | 0 | 0 | 0 | 0 | 2 | 12 |
| MMYEL | 132 | 0 | 0 | 5 | 61 | 10 | 61 |
| MULT | 23 | 0 | 0 | 1 | 12 | 8 | 49 |
| OTHER | 41 | 2 | 104 | 4 | 49 | 8 | 49 |
| PREV | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2896 | 29 | 1513 | 166 | 2022 | 388 | 2364 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 118 | 4 | 209 | 13 | 158 | 27 | 164 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| LEUK | 658 | 12 | 626 | 46 | 560 | 92 | 560 |
| LUNG | 319 | 6 | 313 | 24 | 292 | 61 | 371 |
| OTHER | 36 | 0 | 0 | 1 | 12 | 5 | 30 |
| PEOLC | 129 | 0 | 0 | 5 | 61 | 22 | 134 |
| PREV | 213 | 3 | 157 | 17 | 207 | 44 | 268 |
| SURV | 18 | 0 | 0 | 0 | 0 | 3 | 18 |
| SXQOL | 545 | 10 | 522 | 35 | 426 | 90 | 548 |
| Total | 2046 | 35 | 1827 | 141 | 1716 | 344 | 2093 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1018 | 16 | 835 | 80 | 974 | 171 | 1041 |
| CCD | 118 | 4 | 209 | 13 | 158 | 27 | 164 |
| ERLYTX | 96 | 1 | 52 | 4 | 49 | 7 | 43 |
| GI | 187 | 0 | 0 | 9 | 110 | 22 | 134 |
| GU | 419 | 2 | 104 | 22 | 268 | 52 | 317 |
| LEUK | 798 | 15 | 783 | 55 | 670 | 113 | 688 |
| LUNG | 493 | 10 | 522 | 37 | 450 | 96 | 584 |
| LYMPH | 397 | 1 | 52 | 19 | 231 | 52 | 317 |
| MELAN | 275 | 0 | 0 | 0 | 0 | 2 | 12 |
| MMYEL | 132 | 0 | 0 | 5 | 61 | 10 | 61 |
| MULT | 23 | 0 | 0 | 1 | 12 | 8 | 49 |
| OTHER | 77 | 2 | 104 | 5 | 61 | 13 | 79 |
| PEOLC | 129 | 0 | 0 | 5 | 61 | 22 | 134 |
| PREV | 215 | 3 | 157 | 17 | 207 | 44 | 268 |
| SURV | 18 | 0 | 0 | 0 | 0 | 3 | 18 |
| SXQOL | 547 | 10 | 522 | 35 | 426 | 90 | 548 |
| Total | 4942 | 64 | 3340 | 307 | 3738 | 732 | 4457 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 641 | 13 | 678 | 57 | 694 | 116 | 706 |
| ERLYTX | 47 | 1 | 52 | 2 | 24 | 4 | 24 |
| GI | 134 | 0 | 0 | 5 | 61 | 16 | 97 |
| GU | 353 | 2 | 104 | 21 | 256 | 44 | 268 |
| LEUK | 85 | 3 | 157 | 6 | 73 | 16 | 97 |
| LUNG | 109 | 2 | 104 | 9 | 110 | 18 | 110 |
| LYMPH | 257 | 1 | 52 | 15 | 183 | 40 | 244 |
| MELAN | 173 | 0 | 0 | 0 | 0 | 2 | 12 |
| MMYEL | 83 | 0 | 0 | 4 | 49 | 8 | 49 |
| MULT | 8 | 0 | 0 | 0 | 0 | 2 | 12 |
| OTHER | 41 | 2 | 104 | 4 | 49 | 8 | 49 |
| PREV | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1935 | 24 | 1251 | 123 | 1499 | 274 | 1668 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 105 | 4 | 209 | 11 | 134 | 24 | 146 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| LEUK | 288 | 5 | 261 | 18 | 219 | 40 | 244 |
| LUNG | 199 | 1 | 52 | 14 | 170 | 37 | 225 |
| OTHER | 36 | 0 | 0 | 1 | 12 | 5 | 30 |
| PEOLC | 92 | 0 | 0 | 4 | 49 | 17 | 103 |
| PREV | 212 | 2 | 104 | 16 | 195 | 43 | 262 |
| SURV | 18 | 0 | 0 | 0 | 0 | 3 | 18 |
| SXQOL | 369 | 8 | 417 | 25 | 304 | 61 | 371 |
| Total | 1329 | 20 | 1043 | 89 | 1083 | 230 | 1399 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 826 | 20 | 1044 | 72 | 877 | 142 | 864 |
| CCD | 143 | 6 | 313 | 14 | 170 | 28 | 170 |
| ERLYTX | 57 | 1 | 52 | 2 | 24 | 4 | 24 |
| GI | 136 | 1 | 52 | 5 | 61 | 15 | 91 |
| GU | 373 | 3 | 157 | 21 | 256 | 49 | 298 |
| LEUK | 373 | 8 | 417 | 24 | 292 | 56 | 341 |
| LUNG | 313 | 4 | 209 | 27 | 329 | 58 | 353 |
| LYMPH | 257 | 1 | 52 | 15 | 183 | 40 | 244 |
| MELAN | 173 | 0 | 0 | 0 | 0 | 2 | 12 |
| MMYEL | 66 | 0 | 0 | 4 | 49 | 8 | 49 |
| MULT | 25 | 0 | 0 | 2 | 24 | 5 | 30 |
| OTHER | 252 | 5 | 261 | 13 | 158 | 35 | 213 |
| PEOLC | 96 | 1 | 52 | 4 | 49 | 17 | 103 |
| PREV | 214 | 2 | 104 | 16 | 195 | 43 | 262 |
| SURV | 18 | 0 | 0 | 0 | 0 | 3 | 18 |
| SXQOL | 371 | 8 | 417 | 25 | 304 | 61 | 371 |
| Total | 3693 | 60 | 3130 | 244 | 2971 | 566 | 3443 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 852 | 8 | 417 | 62 | 755 | 132 | 804 |
| ERLYTX | 82 | 1 | 52 | 4 | 49 | 7 | 43 |
| GI | 107 | 0 | 0 | 5 | 61 | 11 | 67 |
| GU | 247 | 1 | 52 | 18 | 219 | 39 | 237 |
| LEUK | 107 | 1 | 52 | 5 | 61 | 12 | 73 |
| LUNG | 139 | 4 | 209 | 10 | 122 | 28 | 170 |
| LYMPH | 323 | 0 | 0 | 15 | 183 | 39 | 237 |
| MMYEL | 119 | 0 | 0 | 3 | 37 | 8 | 49 |
| MULT | 23 | 0 | 0 | 1 | 12 | 8 | 49 |
| Total | 1999 | 15 | 782 | 123 | 1499 | 284 | 1729 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1911 | 22 | 1148 | 122 | 1485 | 305 | 1857 |
| AFFIL | 129 | 1 | 52 | 12 | 146 | 30 | 183 |
| CCOP/NCORP | 1224 | 21 | 1096 | 78 | 950 | 169 | 1029 |
| Non-SWOG | 1676 | 18 | 939 | 93 | 1132 | 226 | 1376 |
| Total | 4940 | 62 | 3235 | 305 | 3713 | 730 | 4445 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GI | S2433 | PANC, KRAS WT, Met, SOC Chemo +/- Panitumumab | 1 | Y | 26-DEC-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | A031801 | GU, mRCC, Cabozantinib ± Radium-223 | 1 | E | 19-DEC-25 |
| ERLYTX | EAY191-S3 | ComboMATCH: Adv Solid Tumors, Pac+Ipatasertib | 1 | T | 18-DEC-25 |
| MELAN | EA6141 | Melan, Adv, Nivolumab+Ipi ± Sargmostim | 1 | E | 08-JAN-26 |
| OTHER | EA3161 | HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo | 1 | E | 07-JAN-26 |
| OTHER | EA3161 | HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo | 2 | E | 07-JAN-26 |
| GI | A021806 | Pancreas, Perioperative vs Adjuvant Chemo | 0 | E | 05-JAN-26 |
| GI | A021806 | Pancreas, Perioperative vs Adjuvant Chemo | 1 | E | 05-JAN-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 12 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 12 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 8 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 6 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 6 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 5 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 5 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 5 |
| OTHER | 10323 | Moonshot Biobank Research | 1 | 3 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |